Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
More positive PhIII data set stage for Scynexis' vaginal yeast infection drug approval
6 years ago
Short attack targets one of the favorites now sharing the lead in the popular KRAS drug development race
6 years ago
Datavant boots up a big Covid-19 registry — looking to shine a light on virus spread, impact and most effective therapies
6 years ago
Coronavirus
Another PhIII win in hand, Cara aims straight for priority review of 'breakthrough' pruritus drug
6 years ago
Pivotal data suggest clean safety profile, potency could set Idorsia's sleeping pill apart
6 years ago
Exelixis lands PhIII kidney cancer win with Bristol Myers in their hunt for $4 billion
6 years ago
NIH corrals biopharma companies, regulators and trial networks to coordinate Covid-19 R&D
6 years ago
Coronavirus
Report on one PhIII remdesivir study sends investors into overdrive, adding billions to Gilead's market cap
6 years ago
Coronavirus
Interim data on Vir's Alnylam-partnered RNAi hep B drug suggest efficacy is broadly on par with J&J, Arrowhead rival — analysts
6 years ago
Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug development
6 years ago
Financing
Startups
Sumitomo subsidiary flashes new way of treating schizophrenia in PhII trial
6 years ago
Ex-GSK chief Andrew Witty summoned back to the frontlines of vaccine development at embattled WHO
6 years ago
Gilead takes a hit after a closely-watched Covid-19 trial of remdesivir is quietly terminated, raising fresh doubts
6 years ago
Coronavirus
As GSK and Sanofi promise to produce a Covid-19 vaccine at Indy 500 speed, some experts start to push back on timelines
6 years ago
Coronavirus
Micro-cap Mei Pharma lands $100M upfront on beleaguered PI3K pathway
6 years ago
Deals
Ploughing through a crowded PD-(L)1 market, BeiGene loads up on promising lung cancer data
6 years ago
China
Pharma
Moderna's mission to spearhead a revolution in vaccine R&D comes center stage today as the world faces a crucial turning point
6 years ago
Coronavirus
Creative or unethical? Researchers’ Covid-19 GoFundMe campaign spurs critics
6 years ago
Coronavirus
In Focus
Q&A: Analyst-turned biotech exec-turned analyst reads the biotech Q1 tea leaves
6 years ago
People
Pharma
AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy
6 years ago
Judge slaps enhanced damages on Gilead/Kite for ‘willful’ patent violation, boosting award to a blockbuster $1.2B — with the meter running
6 years ago
A small remdesivir study with lots of shortcomings suggests it may be working against Covid-19 — and 1 analyst forecasts mid-May rollout
6 years ago
Coronavirus
Natural killers are coming for Covid-19 and the therapy, experts say, could make things worse
6 years ago
Coronavirus
In Focus
Tango Therapeutics nabs $60M in CRISPR-based hunt for hidden cancer genes
6 years ago
Financing
First page
Previous page
205
206
207
208
209
210
211
Next page
Last page